Micro-RNA Expression in Cisplatin Resistant Germ Cell Tumor Cell Lines
Author Information
Author(s): Port Matthias, Glaesener Stephanie, Ruf Christian, Riecke Armin, Bokemeyer Carsten, Meineke Viktor, Honecker Friedemann, Abend Michael
Primary Institution: Hannover Medical School
Hypothesis
We compared microRNA expression patterns in three cisplatin resistant sublines derived from paternal cisplatin sensitive germ cell tumor cell lines to improve our understanding of the mechanisms of cisplatin resistance.
Conclusion
The study confirmed the miR-371-373 cluster as a promising target for explaining cisplatin resistance and identified new micro-RNA species associated with a cisplatin resistant phenotype in human germ cell tumors.
Supporting Evidence
- 72 of 738 microRNAs were differentially expressed between sensitive and resistant cell line pairs.
- 95.3% of differentially expressed genes in NTERA-2-R/NTERA-2 were up-regulated.
- The miR-371-373 cluster was significantly up-regulated in resistant cell lines.
Takeaway
This study looked at tiny molecules called micro-RNAs in cancer cells that are resistant to a drug called cisplatin, helping us understand why some cancer cells don't respond to treatment.
Methodology
The study involved comparing microRNA expression in three cisplatin resistant sublines and their parental sensitive cell lines using quantitative RT-PCR.
Limitations
The study was conducted in vitro, and further functional analyses are needed to confirm the findings in vivo.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website